Related Experiment Videos
Giant cell (cranial) arteritis: a clinical review
Insights
Giant cell arteritis (GCA) is an important vasculitis in the elderly. Prompt diagnosis and high-dose corticosteroid treatment are crucial to prevent vision loss and manage symptoms effectively.
Area of Science:
- Rheumatology
- Internal Medicine
- Geriatrics
Background:
- Giant cell arteritis (GCA) is an underrecognized inflammatory condition affecting the elderly.
- Early recognition and treatment are vital to prevent severe complications such as blindness.
- GCA often presents with constitutional symptoms, headache, jaw claudication, or polymyalgia rheumatica.
Purpose of the Study:
- To highlight the importance of recognizing and diagnosing Giant Cell Arteritis.
- To emphasize the necessity of prompt and effective treatment strategies for GCA.
- To inform about the clinical presentation and diagnostic indicators of GCA.
Main Methods:
- Clinical presentation review including constitutional symptoms, headache, and jaw claudication.
- Physical examination findings focusing on cranial and large vessel involvement.
- Diagnostic confirmation through elevated sedimentation rate and temporal artery biopsy.
Main Results:
- High-dose corticosteroid therapy is effective in symptom relief and preventing complications like blindness.
- Prolonged treatment (1-2 years or longer) with corticosteroids is often required.
- While treatment improves outcomes, long-term follow-up shows no impact on survivorship.
Conclusions:
- Giant cell arteritis requires prompt diagnosis and high-dose corticosteroid treatment to prevent irreversible complications.
- Awareness of GCA's varied presentation in the elderly is essential for timely intervention.
- Long-term corticosteroid therapy is generally well-tolerated and effective for symptom management in GCA.
Abstract:
Giant cell arteritis is a disease of the elderly which is more common than previously recognized. It is important to be aware of this condition because treatment effectively relieves symptoms and prevents serious complications. The disease is suggested when an elderly patient complains of constitutional symptoms, headache, jaw claudication, or the musculoskeletal manifestations of polymyalgia rheumatica. Abnormalities in temporal arteries or other cranial arteries, or evidence of large vessel involvement may be detected by physical examination. A markedly elevated sedimentation rate in association with other clinical features of the disease strongly suggests giant cell arteritis, but a biopsy should be performed to confirm the diagnosis. Corticosteroid therapy should be started promptly in high doses in order to prevent blindness. Prolonged treatment with lower dose corticosteroids is generally necessary for up to 1 to 2 years, and sometimes longer, for continued symptomatic relief. Long-term follow-up of treated patients has demonstrated no detectable effect on survivorship.